We have established an agreement with KU Leuven to analyze immunological serum biomarkers in blood samples from patients enrolled in ImmunoSABR

We have established an agreement with KU Leuven to analyze immunological serum biomarkers in blood samples from patients enrolled in ImmunoSABR. The analysis will utilize a targeted approach with the sFIS assay, enabling detailed insights into immune responses and advancing the project’s research objectives. https://pubmed.ncbi.nlm.nih.gov/34795003/